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Hyperplasia of P ancreatic Islets Associated with 
Extrapancreatic Lymphoma and Sarcoma 
By WILLIAM R. HAHT AND DORIN L. HINERMAN 
A preliminary study revealed pancreatic 
hyperplasia to be present in 29 per cent 
of 100 consecutive necropsies. Malignant 
neoplasms coexisted with hyperplasia of 
islets in 14 (48.3 per cent) of the 29 
cases. On the basis of the results of this 
study, the islets of Langerhans in micro- 
scopic sections of pancreas from 20 cases 
of accidental death (normal controls), 
10 cases of extrapancreatic lymphoma, 
and 12 cases of extrapancreatic sarcoma 
were quantitatively studied. Significant 
hyperplasia of the islets was present in 
both categories of neoplastic disease 
when compared with the islets in the 
control group. The assessment of hyper- 
plasia of pancreatic islets was neither 
difficult nor complex when the observer 
assigned the proper significance to the 
presence of an increased percentage of 
large islets. The method for determining 
hyperplasia of islets and the significance 
of its presence are discussed. (Metab- 
olism 14: No. 11, November, 1158- 
1168, 1965) 
T HE ISLETS OF LANGERHANS constitute an extremely plastic endo- crine organ. Pathologists and others have recognized marked variations 
in structure of the islets in numerous pathologic and physiologic conditions. 
Gomorir stated that the islets responded as a rule by cytologic changes to 
various acute stimuli while chronic stimulation resulted primarily in altera- 
tions in the amount of insular tissue. Hypex-plasia of pancreatic islets has been 
regularly encountered in patients with diabetes mellitus, erythroblastosis 
fetalis, and in infants born of diabetic mothers.’ Lazarus and Volk” listed 
pancreatic fibrosis, due to carcinoma near the ampulla of Vater, to ligation of 
the pancreatic ducts, or in severe cases of fibrosis without obstruction, as 
lesions associated with dense conglomerations of islets resembling “true in- 
sular hypertrophy.” These authors incriminated chronic hyperglycemia as the 
probable stimulus for pancreatic islet hyperplasia following the experimental 
administration of pituitary growth hormone, thyroid hormone, adrenocortico- 
tropic hormone, glucagon and glucocorticosteroids. There have been conflicting 
reports in the literature as to the effects of Addison’s disease on the islets.~~5 
Hyperplasia of the pancreatic islets frequently has been noted in the re- 
ports of necropsies on the patients that had various extrapancreatic malig- 
nant neoplasms at The University of Michigan Medical Center. The object 
of this study was to quantitatively substantiate the existence of this association. 
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MATERIALS AND METHOD 
h I,rrlill,in;lry study 1~;~s ma& to determine the frequency of hyperplasia of pnncrekttic 
is]vth ;mJ the diseases with which it was associated. hlicroscopic sections of p~ncre:~s 
\,‘(‘r(‘ c.\;lminetl from 100 consecutive necropsies at The University of Xlichigan .\ledical 
(:<sntrr, ;mtl th,Lse were gradetl on a subjective basis by one’ observer ~1s to the pr~scn~e 
or al~sencc~ of definite hyperplasia of pkmcreatic islets. Upon completion of gracling, thra 
c~linicul and pathologic diagnoses for each case were recorded. Correlations between II>-- 
~~c~rpla\i:l of islets anal coexistent &sexes Were then mXle. 
‘l’ho results of this study provided the basis for an objrctivr, qu:mtit;ltivr rv;lluation 
of the* Ixmcrcz;ltic islets in patients with malignant nroplasms. Relatively sucklen dc:ltlls 
Ironl gunshot wounds, falls, automobile and motor scooter accitlents, and drownings 
Ixovid~~~] ;L “irormul” control series. Twenty cases were‘ suit;lbk. for use. Review of 
tlracroscopic :judl microscopic findings from postmortem e\aniinwtions rcvealetl no >lI>- 
p;Ln.nt :~ssociat~~tl pathologic conditions that might accolmt for alttmtions in tllc, i\l(sts. 
,kny ,Gd~nc,. of pancreatic diwaw or twlocriw ahnorm:llity c*liminntrtl tlw ~‘a~(~ fuurl 
tII<. <tntly. 
Kullrtsrolls n,etllods for tletrrmining the volume of panrrt,atic islet tissue, xt‘ knower. 
\\.arr<,n and I,k~Comptc2 stated that the most careful qliuntit:ltive study of the islets ot 
I,a~rg:c~rlr;rns 1~;~s that of Tcjninb r(i uhose monograph prcscnictl valid criticism of thr most 
pop~tl:ir tcpchnic3. His data rc~vealetl thitt ts thcv vo111nre of islet tissue incrrasetl, tht~ 
mmlber of islets of all s&s incwasetl. However. tht, increace in number of islets 
\?‘>LS rc,latively more marked in the lnrger islets tll;m in the smalkr ones. Therefork*. 
Tfljning concluded, if in one pancreas :I relatively gre;lter nlmlher of lxgcsr islets w:lh 
O]WWV~] thuu in another p”ncrratic gland. the conclusion wxs just&d that this WIIS ;I 
\iql tll;lt tllc total qu,mtity- of i&t tissue, wiis greater in thr former thnn in the latter. 
'l'lli.\ c,onclllsion permitted closest attention to be directrtl to th[, Inrger-sizr>tl islets its wt. 
(~110~~ to cl0 in this study. 
Although tile number of islets mny vary depending on the location within thr pancrca;t.\, 
the avrxlfic \ize of the islets is th,, samv in all pxts ok the p.mcrtaas.i,N Comparison of 
islet Gye in different pancreases is. therefore. jllstifiecl withollt concern for thr locxtion 
witllin the* glan~l. 
1160 HART AND HINERMAN 
ocular micrometer was utilized to measure the longest diameter of every islet in each 
available slide of pancreas. Only the measurements of islets greater than 115 p in di- 
ameter, a figure below the average diameter of an islet,Jas were recorded since islets 
much smaller than this might not be identified. Data from the control series revealed 
that islets greater than 192 ,.I in their longest diameter were large. The percentage of 
large islets in each case was then calculated from the ratio: 
no. of islets greater than 192 p no. of large islets 
or 
no. of islets greater than 115 p no. of recorded islets 
If this percentage was significantly greater in the pancreatic glands of patients with 
lymphoma or sarcoma than in the normal controls, the presence of hyperplasia of pan- 
creatic islets was assured. 
RESULTS 
Preliminary Study: Definite hyperplasia of pancreatic islets was found in 
material from 29 of the 100 consecutive necropsies examined in the pre- 
liminary control group. In 14 of these 29 cases (48.3 per cent) extrapancreatic 
malignant neoplasms were also present. In the absence of coexisting diabetes 
mellitus or interstitial pancreatitis, hyperplasia of islets was rarely en- 
countered in patients who died from such chronic illnesses as arteriosclerotic 
heart disease or chronic renal disease. 
Quantitatirje Study. Table 1 presents the important data relevant to the con- 
trol group of 20 patients who were victims of accidental death. The per- 
centage of large islets ranged from 13.0 to 46.9 with a mean of 26.9. An 
analysis of the data revealed no correlation between the age or weight of the 
patient, weight of the pancreas, or percentage of large pancreatic islets. Figure 
1 is a photomicrograph of a representative pancreatic islet of average size 
from a case of accidental death. 
The group of extrapancreatic lymphomas included 10 patients. The im- 
portant details and the percentage of large islets in each case are listed in 
table 2. The range of percentage of large islets was from 15.4 to 59.5 with a 
mean of 40.1. Statistical analysis of the data from table 1 (normal controls) 
and table 2 indicated the difference in the percentages of large islets to be 
significant (p < 0.005).* Figure 2 is a photomicrograph illustrating a hyper- 
plastic pancreatic islet from a case of extrapancreatic lymphoma. 
Table 3 lists the 12 cases of extrapancreatic sarcomas. The percentage of 
large islets in this group ranged from 22.3 to 45.7 with a mean of 34.2. 
Statistical analysis of the data from table 1 (normal controls) and table 3 
indicated the difference in the percentages of large islets to be significant 
(p < 0.01). 
The frequency distribution of the percentage of large islets for each of the 
3 groups of patients is presented in figure 3. In 11 of the 20 cases of ac- 
cidental death in the control group, the large islets comprised greater than 25 
per cent of the total number of recorded islets. In 9 of the 10 cases in the 
extrapancreatic lymphoma group and in 11 of the 12 cases in the extrapan- 
“Normal approximation of the Rank-Sum test. 
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crcatic sarcoma group, the large islets comprised greater than 25 per cent of 
the total number of recorded islets. In 3 of the lymphoma cases (30 per cent). 
the large islets numbered more than one half of the total. 
These results indicated an increased amount of insular tissue in srlrctcd 
causes of patients who died with lymphomas and sarcomas. There was hvpcr- 
plasia of pancreatic islets manifested by a readily apparent increase in th(, 
percentage of large islets. Interestingly, pancreases from cases that were (xx- 
~lucletl from the series becansr~ of microscopic invasion of the gland bv nco- 
plastic, tissnc, showed similar degrees of hvperplasia of islets. 
Thv association of hypcrplwsia of pancreatic islets with extrapancreatic 
Iymphomas and sarcomas has been illustrated by this study. Known causes 
for hvperplasia of tissue including irritations1 & mechanical factors, coin- 
ptmsatory enlargement secondary to loss of actual tissue substance, and bor- 
monal imbalance have been eliminated as much as possible in all cases. UII- 
less one chooses to invoke the etiology “unknown,” it is necessary to formulate 
some hvpothrsis in order to direct attention to the existence of this associa- 
tion. 
The relationship of neoplastic tissue to carbohydrate metabolism has bcc,11 
intcnsiveIy studied since the work by M’arburg” demonstrated altered metabol- 
ic pathways in malignant cells. Neoplastic tissues possess an extraordinarilv 
high rate of anaerobic and aerobic glycolysis. “‘.’ ’ This relatively increased de- 
mand for glucose could merely be due to the inordinately high rate of cellular 
proliferation. Susman” reported 3 cases of malignant disease which had a11 
increase in percentage of islet tissue and 4 additional c.tses that had islets of 
incrcascd size. He attributed this to an increase in carbohydrate metabolism 
which was necessary for the rapid grolvth of the neoplasm. Less energv 1~ 
glucose molecule is obtainable from fermentation than from cellular rcspira- 
torv pathways and respiration appears to be less active in tumors than in most 
normal tissues.!’ This might also account for the relatively great need for gh- 
cost’ 1~ some neoplasms. 
In &eir review article on the nutrition of tumors. Henderson and LePagc’” 
noted that the transplantation of neoplastic tissue ( NovikoE hepatoma and 
\$falktr carcinoma 256) resulted in reduction of the blood sugar levels of al- 
loxanized rats and that mousth tumors decreased the blood sugar levels of 
hcrc~ditarv obese-hyperglycemic mice and alloxan diabetic mice. The sugar 
content o? the tumors was increased under these conditions. Furthermore, de- 
pancrc~ntized rats with the Walker tumor had less glycosuria than did the ch- 
pancrcatized control animals. A4pparcntly some neoplastic tissues do not rc- 
quire insulin for utilization of glucose. Kitt and Griffin” remarked that tumors 
differ in their sensitivity to insulin and anti-insulin hormones. 
Marks and Bishopl” reported that selected patients with chronic leukemia, 
lvmphoma and clinically early epithelial neoplasms manifested a decrtased 
~lncos~ tolerance as studied bv the intravenous glucose tolerance test. Both 
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1 ReticuIum cell 
sarcoma 
2 Reticulum cell 
sarcoma 
3 Hodgkin’s disease 
4 Hodgkin’s disease 
5 Hodgkin’s disease 
6 Hodgkin’s disease 
7 Hodgkin’s disease 
8 Hodgkin’s disease 
9 Hodgkin’s disease 
10 Hodgkin’s disease 
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of No. of I.awe Islets of 
Pancreas - Im-ge 
(Gm.) No. of Recorded Islets Islets 
70 17 21.9 
61 
100 x 32.0 
- 
25 
1 IO 55.8 
1X 
120 47 59.5 
79 
120 2!) 39.2 
- 
74 
180 Ii 15.4 
3r, 
1 IO XG ?A.6 
107 
iO IR 36.7 
49 
110 52 49.5 
105 




Mean percentage of large islets: 40.1 
slower. They suggested that the defect in carbohydrate metabolism reflected 
alterations in the metabolism of host tissue associated with the presence of the 
neoplastic process and was probably not attributable to the carbohydrate 
metabolism of the tumor. 
Indeed an hypothesis could be formulated with some justification that neo- 
plasms may produce an anti-insulin metabolite capable of inactivating to some 
extent the peripheral utilization of glucose by the host, thereby diverting glu- 
cose to the neoplasm. Since insulin may not be required for glucose utiliza- 
tion by the neoplastic cells, the neoplasm would be teleologically benefited by 
such circumstances. The diabetic type glucose tolerance test in patients with 
neoplastic disease could also be a result of such an anti-insulin factor. Such a 
chain of events could account for the hyperplasia of the pancreatic islets in 
response to the increased demand by the host tissue for insulinogenesis. 
Of paramount importance in substantiating these speculations is the dif- 
ferential staining of the islet cells. This might help to determine the functional 
activity of these hyperplastic islets. Such a staining procedure, however, re- 
quires special technics that could not be performed on the microscopic slides 
utilized in this study. 
The pancreatic islets can be linked to metabolism and tissue growth in yet 
another fashion. Glucagon and insulin have both been incriminated as factors 
in growth promotion. Salter and Best14 reported that insulin promoted growth 
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Fig. l.-(Case 10, table 1.) Islet of Langerhans of average size from a cze of 
wciclental death. H. & E., X145. 
Fig. 2.-(Case 29, table 2.) Hyperplastic islet of Langerhans from a case ot 
extrapancreatic lymphoma. H. & E., X14*5. 
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Table 3.-Extrapancreatic Sarcomas 



















of No. of Lawe Islets of 
Pancreas _~__._~~~ I,arae 
(Grn.) No. of Recorded Islets Islets 
51) 53 43.x 
121 
121, n5 2X.!) 
121 
ii, :o\ 37.3 
102 
70 x0 X.6 
!I” 
kll 20 ::O.X 
6.5 
60 1x 311.5 
- 
59 
‘! :x1 “2.3 
1 ?!I 
x4 66 :3!l.h 
1 lx 
;I, IO : : r, 7 
2x 
.;0 17 :?5.4 
- 
4x 
? x 27.fi 
29 
,;5 F4 45.7 
-. 
140 
in hvl~ophysectomized rats. Cavallero15 consider4 glucagon &O to 1~ a11 
active growth-stimulating factor capable of inducing “true growth” in cm- 
brvonic life as well as in pituitary dwarfism. Perhaps these pancreatic cndo- 
crine hormones also stimulate the growth of neoplastic tissue. 
Case reports of patients manifesting hypoglycemia and extrapancreatic nco- 
plasms” are numerous in the literature. Histologic evidence of increased islet 
cell activity has not yet been observed in such patients. As this study illustrates, 
it is important to realize that hyperplasia of islets may coexist with extrapan- 
erratic neoplasms in patients who do not have hypoglycemia. Recognition 
of this will prove valuable in future studies of the pancreas in patients with 
the hypoglycemia-neoplasia association. 
Whatever the implications of the association between hyperplasia of islets 
and cxtrapancreatic neoplasia may be, the need for more careful morphologic, 
1168 HART AND HINERMAN 
biochemical and immunologic correlations in patients with neoplastic disease 
has been demonstrated. 
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